Yposkesi accueille le groupe SK comme nouvel actionnaire majoritaire à son capital et noue ainsi un solide partenariat industriel de croissance
Yposkesi to give talk on gene therapy vectors at Virtual Cell & Gene Meeting on the Mediterranean, April 6 – 9, 2021
Cell-Easy strengthens executive team with two new highly experienced members
Chiesi and Hephaï join forces to develop AI educational tool to improve inhaler use
REGEnLIFE presents first results of pilot clinical trial evaluating photobiomodulation technology in the treatment of Alzheimer’s disease
• Within treated patient group, trends showed improved cognitive and executive functions, improved language comprehension and verbal memory, in comparison to placebo group
• REGEnLIFE’s technology shown to be safe and well-tolerated by patients
• Initial results open up new possibilities for development of brain-gut stimulation device for prevention and treatment of neurodegenerative diseases
Seekyo raises over €650,000 from business angels and Bpifrance
Advent France Biotechnology appoints Alejo Chorny, PhD, as operating partner and head of new Spanish operations
OncoDiag raises €2.5M ($3M) to develop its diagnostic testing for early detection of cancer
AELIX Therapeutics presents positive results from randomized placebo-controlled phase I/IIa therapeutic HIV vaccine clinical trial
• Investigational AELIX HTI vaccine leads to prolonged period without antiretroviral treatment (ART)
• Vaccine-induced immune T cell responses significantly correlate with prolonged time off ART
• Results support development of combination strategies based on HTI vaccine to control HIV – without the need for ongoing antiretroviral medication